late sodium current modulators (Gilead Palo Alto)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug Namelate sodium current modulators (Gilead Palo Alto)

Drug Alias Namelate sodium current modulators (CV Therapeutics)late INa modulators (CV Therapeutics)sodium channel inhibitor DHP-3CVT-012000CVT-013064 +[6]

ClassificationSmall molecules

Mechanisms of ActionSodium channels modulators

TargetsSodium channels

Therapy Area/IndicationsCoronary Artery Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGilead Palo Alto Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGilead Palo Alto Inc

Active IndicationsN/A

Inactive IndicationsCoronary Artery Disease

Other Information

ATC CodeN/A